Colorectal cancer(CRC)is the third most common cancer worldwide and represents a serious global health issue.During the disease course,up to 50%of patients will develop liver metastases[colorectal liver metastasis(CRL...Colorectal cancer(CRC)is the third most common cancer worldwide and represents a serious global health issue.During the disease course,up to 50%of patients will develop liver metastases[colorectal liver metastasis(CRLM)]with a significant negative impact on survival(1,2).Liver resection(LR),in combination with chemo-and targeted therapies,is the standard curative treatment for CRLM.In selected patients and in specialized centers,the 5-year overall survival(OS)after LR may reach 50%(3,4).展开更多
文摘Colorectal cancer(CRC)is the third most common cancer worldwide and represents a serious global health issue.During the disease course,up to 50%of patients will develop liver metastases[colorectal liver metastasis(CRLM)]with a significant negative impact on survival(1,2).Liver resection(LR),in combination with chemo-and targeted therapies,is the standard curative treatment for CRLM.In selected patients and in specialized centers,the 5-year overall survival(OS)after LR may reach 50%(3,4).
